Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies
Radice, P.A.; Bunn, P.A.; Ihde, D.C.
Cancer Treatment Reports 63(8): 1231-1239
1979
ISSN/ISBN: 0361-5960 PMID: 225026 Document Number: 139721
Document emailed within 1 workday
Related Documents
Alekseenko, O.I. 2004: Cytogenetic features of the differential diagnosis of lymphoid thymomas, small-cell non-Hodgkin lymphomas and undifferentiated small cell lung carcinoma Tsitologiia i Genetika 38(2): 51-54Saxman, S.B.; West, P.J.; Cheson, B.D. 2001: Clinical trials referral resource. Current clinical trials in small-cell lung cancer Oncology 15(3): 318-319; 323
Fukuoka, M.; Masuda, N.; Kudoh, S.; Negoro, S. 2000: Irinotecan in small-cell lung cancer--Japanese trials Oncology 14(7 Suppl. 5): 57-62
Kosmidis, P.A.; Samantas, E.; Fountzilas, G.; Pavlidis, N.; Apostolopoulou, F.; Skarlos, D. 1994: Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase IIi study. Hellenic Cooperative Oncology Group for Lung Cancer Trials Seminars in Oncology 21(3 Suppl 6: 23-30
Cheson, B.D.; Phillips, P.H.; Feigal, E.G. 1994: Clinical trials referral resource. Non-small-cell lung cancer Oncology 8(2): 56; 61, 65
Cheson, B.D. 1990: Clinical trials referral resource. NCI-Navy: small cell lung cancer Oncology 4(9): 129-130
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Smith, I.E.; Harland, S.J.; Robinson, B.A.; Evans, B.D.; Goodhart, L.C.; Calvert, A.H.; Yarnold, J.; Glees, J.P.; Baker, J.; Ford, H.T. 1985: Carboplatin: a very active new cisplatin analog in the treatment of small cell lung cancer Cancer Treatment Reports 69(1): 43-46
Perevodchikova, N.I. 1995: Small-cell lung cancer--the characteristics of its diagnosis and of the therapeutic procedure Terapevticheskii Arkhiv 67(10): 55-56; 58-59
Huang, G-jun.; Fang, D-kang.; Cheng, G-yu.; Zhang, D-chao. 2006: Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis Zhonghua Zhong Liu Za Zhi 28(1): 62-64
Xiao, Y.-Y.; Zhan, P.; Yuan, D.-M.; Liu, H.-B.; Lv, T.-F.; Shi, Y.; Song, Y. 2013: Chemotherapy plus Vandetanib or chemotherapy alone in advanced non-small cell lung cancer: a meta-analysis of four randomised controlled trials Clinical Oncology 25(1): E7
Munzuroglu, F.; Erturan, S.; Oz, B.; Dincbas, F.O.; Demir, G. 2009: Non small cell lung cancer within the small cell lung cancer radiotherapy field after 11 years Journal of Buon: Official Journal of the Balkan Union of Oncology 14(2): 313-316
Bando, T.; Fujimura, M.; Kasahara, K.; Matsuda, T. 1998: Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines Anticancer Research 18(2a): 1085-1089
Suchi, T.; Motoori, T. 1986: The problems in the histopathological classification of non-Hodgkin's lymphomas--with special references to T-cell lymphomas Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(3 Pt 1): 412-420
Kapoor, S. 2012: Prognostic significance of vascular endothelial growth factor C in systemic malignancies besides non-small cell lung carcinomas Annals of the Academy of Medicine Singapore 41(6): 273-274
Doyle, L.A.; Cuttitta, F.; Mulshine, J.L.; Bunn, P.A.; Minna, J.D. 1987: Markedly different antibody responses to immunized small cell and non-small cell lung cancer cells Cancer Research 47(19): 5009-5013
Kobyakov, D.S.; Avdalyan, A.M.; Lazarev, A.F.; Lushnikova, Y.L.; Nepomnyashikh, L.M. 2015: The Processes of cell Proliferation, Apoptosis and Angiogenesis in Pathologically Unchanged Lung and in Non-Small cell Lung Cancer Morfologiia 148(5): 65-70
Cheson, B.D.; Feigal, E.G. 1993: Clinical trials referral resource. AIDS-related non-Hodgkin's lymphomas Oncology 7(4): 37-38
Li, J.; Hong, Q.; Zhang, X.; Hu, J.; Bai, C. 2014: Therapeutic efficacy and safety of chemotherapy subsequent EGFR-TKi in advanced non-small cell lung cancer patients with EGFR-TKi acquired resistance Zhonghua Yi Xue Za Zhi 94(30): 2342-2345
Levin, W.J.; Press, M.F.; Gaynor, R.B.; Sukhatme, V.P.; Boone, T.C.; Reissmann, P.T.; Figlin, R.A.; Holmes, E.C.; Souza, L.M.; Slamon, D.J. 1995: Expression patterns of immediate early transcription factors in human non-small cell lung cancer. the Lung Cancer Study Group Oncogene 11(7): 1261-1269